AZURE-2 evaluates the efficacy and safety of brelovitug as a monotherapy compared head-to-head with Hepcludex ...

Bluejay Therapeutics has enrolled the first patient in AZURE-2, a global phase 3 clinical trial evaluating brelovitug ...

The trial's primary goal is to measure the proportion of subjects achieving a composite response at the mark of week 48.

A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1) | MedPage Today | MedPage ...

Microsoft introduces a file share-centric model for Azure Files, removing storage account complexity and offering more ...

Veeam introduced its first software-only, hardware-agnostic appliance for backup and recovery, delivering a hardened Linux deployment with built-in immutability, automated patching, and Instant ...